These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36748182)
1. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion. Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours. Yamamoto H; Nozaki Y; Kohashi K; Kinoshita I; Oda Y Histopathology; 2020 Apr; 76(5):774-778. PubMed ID: 31578734 [TBL] [Abstract][Full Text] [Related]
3. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767 [TBL] [Abstract][Full Text] [Related]
4. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Alassiri AH; Ali RH; Shen Y; Lum A; Strahlendorf C; Deyell R; Rassekh R; Sorensen PH; Laskin J; Marra M; Yip S; Lee CH; Ng TL Am J Surg Pathol; 2016 Aug; 40(8):1051-61. PubMed ID: 27259007 [TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
7. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets. Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480 [TBL] [Abstract][Full Text] [Related]
8. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion. Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155 [TBL] [Abstract][Full Text] [Related]
9. A unique case of inflammatory myofibroblastic tumor of the liver manifesting with biloma: A case report. Huang K; Zhao P; Zhao J; Zhao P; Yang J Oncol Lett; 2022 Jul; 24(1):227. PubMed ID: 35720485 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors. Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984 [TBL] [Abstract][Full Text] [Related]
11. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]
12. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma. Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological features of inflammatory myofibroblastic tumor]. Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881 [No Abstract] [Full Text] [Related]
14. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report. Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions. Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187 [TBL] [Abstract][Full Text] [Related]
16. Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing. Yao Q; Bai Q; Zhang X; Ji G; Chang H; Cai X; Yu L; Wang J; Zhu X; Zhou X Arch Pathol Lab Med; 2022 Oct; 146(10):1234-1242. PubMed ID: 35041745 [TBL] [Abstract][Full Text] [Related]
17. Spectrum of kinase gene rearrangements in a large series of paediatric inflammatory myofibroblastic tumours. Preobrazhenskaya EV; Suleymanova AM; Bizin IV; Zagrebin FA; Romanko AA; Saitova ES; Mulkidzhan RS; Imyanitov EN Histopathology; 2023 Jul; 83(1):109-115. PubMed ID: 37071060 [TBL] [Abstract][Full Text] [Related]
18. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene. Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481 [TBL] [Abstract][Full Text] [Related]
19. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797 [TBL] [Abstract][Full Text] [Related]